MA53828A - Compositions et méthodes pour le traitement d'infections pathogènes dans des plantes - Google Patents

Compositions et méthodes pour le traitement d'infections pathogènes dans des plantes

Info

Publication number
MA53828A
MA53828A MA053828A MA53828A MA53828A MA 53828 A MA53828 A MA 53828A MA 053828 A MA053828 A MA 053828A MA 53828 A MA53828 A MA 53828A MA 53828 A MA53828 A MA 53828A
Authority
MA
Morocco
Prior art keywords
plants
compositions
methods
pathogenic infections
treating pathogenic
Prior art date
Application number
MA053828A
Other languages
English (en)
Inventor
Goutam Gupta
Eddie W Stover
Original Assignee
Innate Immunity LLC
Us Agriculture
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innate Immunity LLC, Us Agriculture filed Critical Innate Immunity LLC
Publication of MA53828A publication Critical patent/MA53828A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01H—NEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
    • A01H3/00—Processes for modifying phenotypes, e.g. symbiosis with bacteria
    • A01H3/04—Processes for modifying phenotypes, e.g. symbiosis with bacteria by treatment with chemicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
    • C12N15/8237—Externally regulated expression systems
    • C12N15/8239—Externally regulated expression systems pathogen inducible
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
    • C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
    • C12N15/8281—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for bacterial resistance
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Plant Pathology (AREA)
  • Botany (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Environmental Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MA053828A 2018-10-01 2019-10-01 Compositions et méthodes pour le traitement d'infections pathogènes dans des plantes MA53828A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16/148,848 US20200102356A1 (en) 2018-10-01 2018-10-01 Compositions and Methods for the Treatment of Huanglongbing (HLB) aka Citrus Greening in Citrus Plants

Publications (1)

Publication Number Publication Date
MA53828A true MA53828A (fr) 2022-01-05

Family

ID=69945419

Family Applications (1)

Application Number Title Priority Date Filing Date
MA053828A MA53828A (fr) 2018-10-01 2019-10-01 Compositions et méthodes pour le traitement d'infections pathogènes dans des plantes

Country Status (8)

Country Link
US (1) US20200102356A1 (fr)
EP (1) EP3860619A4 (fr)
CN (1) CN113164513A (fr)
AU (1) AU2019351903A1 (fr)
BR (1) BR112021006310A2 (fr)
MA (1) MA53828A (fr)
MX (1) MX2021003849A (fr)
WO (1) WO2020072535A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112640711B (zh) * 2020-12-24 2022-09-20 深圳市硒惠农生物科技有限公司 一种防治柚子树黄龙病的方法
CN113402613B (zh) * 2021-01-19 2022-06-14 东北农业大学 抗菌肽ll37活性中心衍生肽二倍体抗菌肽lg及其制备方法和应用
US20240279313A1 (en) * 2021-08-11 2024-08-22 The Regents Of The University Of California Barrier function preserving peptides for membranes
CN114573672B (zh) * 2022-03-21 2022-10-04 中国农业科学院农业基因组研究所 西瓜苦味物质葫芦素e的转运蛋白及其应用
WO2023201129A1 (fr) * 2022-04-12 2023-10-19 NMC Inc. Peptides chimériques antibactériens et leurs méthodes d'utilisation thérapeutique
CN116715733A (zh) * 2022-10-18 2023-09-08 深圳润康生态环境股份有限公司 一种有效抑制柑橘黄龙病病原菌增殖的抗菌肽stj-2及其应用
WO2024145551A1 (fr) 2022-12-29 2024-07-04 Biotalys NV Compositions agrochimiques
WO2024141645A1 (fr) 2022-12-30 2024-07-04 Biotalys N.V. Agglomérat
WO2024141641A2 (fr) 2022-12-30 2024-07-04 Biotalys NV Signaux de sécrétion
WO2024141638A1 (fr) 2022-12-30 2024-07-04 Biotalys NV Concentré auto-émulsifiable

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU693098B2 (en) * 1993-06-09 1998-06-25 Connaught Laboratories Limited Tandem synthetic HIV-1 peptides
WO2004104169A2 (fr) * 2003-05-14 2004-12-02 Integrated Plant Genetics, Inc. Identification et utilisation de genes codant des proteines holines et du type holine dans les plantes pour lutter contre les microbes et les parasites
US8212110B2 (en) * 2003-05-14 2012-07-03 Integrated Plant Genetics, Inc. Use of bacteriophage outer membrane breaching proteins expressed in plants for the control of gram-negative bacteria
US9181310B2 (en) * 2003-05-14 2015-11-10 University Of Florida Research Foundation, Inc. Use of bacteriophage outer membrane breaching proteins expressed in plants for the control of gram-negative bacteria
WO2005019242A2 (fr) * 2003-08-18 2005-03-03 E.I. Dupont De Nemours And Company Expression de recombinaison du peptide hag1 anti-microbien: utilisation en tant que partenaire de fusion pour l'expression de peptides alpha helicoidaux antimicrobiens
JP2007530697A (ja) * 2004-03-29 2007-11-01 ジ・アリゾナ・ボード・オブ・リージェンツ・オン・ビハーフ・オブ・ザ・ユニバーシティー・オブ・アリゾナ 両親媒性グリコペプチド
US7572771B1 (en) * 2004-10-15 2009-08-11 The United States Of America As Represented By The Departments Of Health And Human Services Multi-domain amphipathic helical peptides and methods of their use
US20090119793A1 (en) * 2005-01-26 2009-05-07 Washington State University Research Foundation Plant Defense Signal Peptides
US8940864B2 (en) * 2006-10-05 2015-01-27 New York Blood Center, Inc. Stabilized therapeutic small helical antiviral peptides
EP2120983A4 (fr) * 2006-12-21 2010-10-13 Us Army Composés peptidomimétiques antimicrobiens et procédés d'évaluation d'activité antimicrobienne
CA2675024A1 (fr) * 2007-01-10 2008-07-17 University Of Saskatchewan Stabilisation de structures de peptides cycliques
ES2548767T3 (es) * 2007-01-16 2015-10-20 The Regents Of The University Of California Nuevos péptidos antimicrobianos
GB0821687D0 (en) * 2008-11-28 2008-12-31 Secr Defence Peptides
WO2011049914A2 (fr) * 2009-10-22 2011-04-28 Board Of Regents Of The University Of Nebraska Peptides anti-vih et méthodes d'utilisation
WO2015057009A1 (fr) * 2013-10-17 2015-04-23 서울대학교산학협력단 Multimère de peptides de pénétration cellulaire à hélice alpha, procédé de préparation associé et utilisation associée
CA2963478A1 (fr) * 2014-10-14 2016-04-21 Riptide Bioscience, Inc. Peptides ayant des proprietes anti-inflammatoires
WO2016154328A2 (fr) * 2015-03-23 2016-09-29 Riptide Bioscience, Inc. Peptides antimicrobiens et leurs méthodes d'utilisations
US10611799B2 (en) * 2017-03-03 2020-04-07 National Tsing Hua University Anti-endotoxin polypeptide

Also Published As

Publication number Publication date
US20200102356A1 (en) 2020-04-02
EP3860619A4 (fr) 2022-10-26
AU2019351903A1 (en) 2021-05-13
WO2020072535A1 (fr) 2020-04-09
BR112021006310A2 (pt) 2021-08-31
EP3860619A1 (fr) 2021-08-11
CN113164513A (zh) 2021-07-23
MX2021003849A (es) 2021-09-08

Similar Documents

Publication Publication Date Title
MA53828A (fr) Compositions et méthodes pour le traitement d'infections pathogènes dans des plantes
MA52232A (fr) Inhibiteurs hétérobicycliques de mat2a et leurs méthodes d'utilisation pour le traitement du cancer
MA53558A (fr) Compositions et procédés pour le traitement d'infections virales
MA45539A (fr) Dihydropyranopyrimidines pour le traitement d'infections virales
MA52861A (fr) Méthodes et compositions pour le traitement de l'apnée du sommeil
MA44083A (fr) Composés de biarylmonobactame pour le traitement d'infections bactériennes
MA43811A (fr) Composés d'arylmonobactame bicycliques et leurs méthodes d'utilisation pour le traitement des infections bactériennes
MA46954A (fr) Méthodes de traitement d'états inflammatoires
MA49576A (fr) Compositions et méthodes pour le traitement d'infections fongiques
MA52631A (fr) Compositions et méthodes pour le traitement de la maladie de parkinson
MA51056A (fr) Compositions et méthodes pour le traitement d'affections métaboliques
MA49069A (fr) Procédés et compositions pour le traitement d'apnée du sommeil
MA47504A (fr) Composés et méthodes de traitement de l'angiocholite biliaire primitive
MA44737A (fr) Compositions pour le traitement de troubles liés à l'hyperkératose
MA44426B1 (fr) Compositions et méthodes pour diminier l'expression de tau
MA51677A (fr) Méthodes de traitement du cancer à l'aide d'anticorps anti-pd-1
MA43982A (fr) Anticorps anti-tnf, compositions, méthodes et utilisation pour le traitement ou la prévention du diabète de type 1
MA53329A (fr) Méthodes de traitement de l'épilepsie
MA53445A (fr) Procédés et compositions pour la modification de plantes
MA52971A (fr) Compositions et procédés pour le traitement de l'infiltration de graisse dans le muscle
MA53873A (fr) Compositions et procédés pour le traitement de la presbytie
MA46750A (fr) Méthodes de traitement de l'htap à l'aide de combinaisons de ralinepag et d'autres agents
MA54792A (fr) Compositions et méthodes pour le traitement de la maladie de parkinson
MA51788A (fr) Substances et méthodes pour traiter des hémoglobinopathies
MA51678A (fr) Méthodes de traitement de l'amyotrophie musculaire